Skip to main content
Premium Trial:

Request an Annual Quote

ResearchDx, CompanDx Form Partnership Aimed at Companion Dx Development

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – ResearchDx today announced a partnership with CompanDx that it said will result in "a full capability to discover and deliver novel molecular diagnostic tests."

The collaboration draws on ResearchDx's ability to design, produce, and validate tests, and CompanDx's Distiller platform to deliver small composite biomarker signatures from complex data of high dimensionality. As a result, clients will be able to initiate the parallel development of companion diagnostics from the earliest stages of drug development, ResearchDx said.

Financial and other terms of the deal were not disclosed.

Based in Irvine, Calif., ResearchDx is a contract diagnostics organization for the biopharmaceutical and diagnostic industries.

CompanDx is a molecular diagnostics firm based in Nottingham, UK. Earlier this year it and Clinical Reference Laboratory announced a collaboration to develop biomarker panels and companion diagnostics.

The Scan

UK Pilot Study Suggests Digital Pathway May Expand BRCA Testing in Breast Cancer

A randomized pilot study in the Journal of Medical Genetics points to similar outcomes for breast cancer patients receiving germline BRCA testing through fully digital or partially digital testing pathways.

Survey Sees Genetic Literacy on the Rise, Though Further Education Needed

Survey participants appear to have higher genetic familiarity, knowledge, and skills compared to 2013, though 'room for improvement' remains, an AJHG paper finds.

Study Reveals Molecular, Clinical Features in Colorectal Cancer Cases Involving Multiple Primary Tumors

Researchers compare mismatch repair, microsatellite instability, and tumor mutation burden patterns in synchronous multiple- or single primary colorectal cancers.

FarGen Phase One Sequences Exomes of Nearly 500 From Faroe Islands

The analysis in the European Journal of Human Genetics finds few rare variants and limited geographic structure among Faroese individuals.